documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
47 rows where docket_id = "FDA-1995-N-0054" and posted_year = 1997 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: title, subtype, posted_date, posted_month, last_modified, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1995-N-0054-0003 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | FDA | Notice | NEC-Notice of Extension | 1997-09-17T04:00:00Z | 1997 | 9 | 1997-09-17T04:00:00Z | 1997-12-03T04:59:59Z | 2008-05-16T22:28:01Z | 0 | 0 | 0900006480563bb8 | |
| FDA-1995-N-0054-0002 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1997-08-22T04:00:00Z | 1997 | 8 | 2008-05-16T22:28:56Z | 0 | 0 | 0900006480563a27 | |||
| FDA-1995-N-0054-13910 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:32:00Z | 0 | 0 | 090000648056b92d | |||
| FDA-1995-N-0054-13901 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:27:51Z | 0 | 0 | 090000648056b90e | |||
| FDA-1995-N-0054-13926 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:32:00Z | 0 | 0 | 090000648056b94f | |||
| FDA-1995-N-0054-13916 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:31:17Z | 0 | 0 | 090000648056b93a | |||
| FDA-1995-N-0054-13917 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:27:51Z | 0 | 0 | 090000648056b93c | |||
| FDA-1995-N-0054-13906 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:30:32Z | 0 | 0 | 090000648056b922 | |||
| FDA-1995-N-0054-13902 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:33:27Z | 0 | 0 | 090000648056b913 | |||
| FDA-1995-N-0054-13918 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:28:40Z | 0 | 0 | 090000648056b93f | |||
| FDA-1995-N-0054-0001 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 1997-06-06T04:00:00Z | 1997 | 6 | 1997-06-06T04:00:00Z | 1997-08-19T03:59:59Z | 2008-05-16T22:32:03Z | 0 | 0 | 090000648056205b | |
| FDA-1995-N-0054-13904 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:33:27Z | 0 | 0 | 090000648056b918 | |||
| FDA-1995-N-0054-13933 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:28:40Z | 0 | 0 | 090000648056b97c | |||
| FDA-1995-N-0054-13908 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:33:27Z | 0 | 0 | 090000648056b927 | |||
| FDA-1995-N-0054-13905 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:30:32Z | 0 | 0 | 090000648056b91a | |||
| FDA-1995-N-0054-13923 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:29:25Z | 0 | 0 | 090000648056b94a | |||
| FDA-1995-N-0054-13927 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:31:17Z | 0 | 0 | 090000648056b951 | |||
| FDA-1995-N-0054-13937 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:29:25Z | 0 | 0 | 090000648056b986 | |||
| FDA-1995-N-0054-13941 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:27:53Z | 0 | 0 | 090000648056b98e | |||
| FDA-1995-N-0054-13940 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:32:45Z | 0 | 0 | 090000648056b98c | |||
| FDA-1995-N-0054-13919 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:28:40Z | 0 | 0 | 090000648056b942 | |||
| FDA-1995-N-0054-13929 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:32:00Z | 0 | 0 | 090000648056b956 | |||
| FDA-1995-N-0054-13939 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:31:18Z | 0 | 0 | 090000648056b98a | |||
| FDA-1995-N-0054-13921 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:32:00Z | 0 | 0 | 090000648056b945 | |||
| FDA-1995-N-0054-13915 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:27:51Z | 0 | 0 | 090000648056b937 | |||
| FDA-1995-N-0054-13924 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:32:44Z | 0 | 0 | 090000648056b94c | |||
| FDA-1995-N-0054-13944 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:28:41Z | 0 | 0 | 090000648056b999 | |||
| FDA-1995-N-0054-13903 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:32:43Z | 0 | 0 | 090000648056b915 | |||
| FDA-1995-N-0054-13920 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:32:00Z | 0 | 0 | 090000648056b943 | |||
| FDA-1995-N-0054-13930 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:29:25Z | 0 | 0 | 090000648056b958 | |||
| FDA-1995-N-0054-13938 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:32:01Z | 0 | 0 | 090000648056b988 | |||
| FDA-1995-N-0054-13907 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:27:51Z | 0 | 0 | 090000648056b924 | |||
| FDA-1995-N-0054-13934 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:27:52Z | 0 | 0 | 090000648056b97e | |||
| FDA-1995-N-0054-13936 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:32:45Z | 0 | 0 | 090000648056b984 | |||
| FDA-1995-N-0054-13909 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:28:40Z | 0 | 0 | 090000648056b92a | |||
| FDA-1995-N-0054-13935 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:30:33Z | 0 | 0 | 090000648056b980 | |||
| FDA-1995-N-0054-13913 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:33:27Z | 0 | 0 | 090000648056b933 | |||
| FDA-1995-N-0054-13914 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:32:44Z | 0 | 0 | 090000648056b935 | |||
| FDA-1995-N-0054-13928 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:30:33Z | 0 | 0 | 090000648056b954 | |||
| FDA-1995-N-0054-13932 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:27:52Z | 0 | 0 | 090000648056b97a | |||
| FDA-1995-N-0054-13942 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:29:25Z | 0 | 0 | 090000648056b990 | |||
| FDA-1995-N-0054-13922 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:32:00Z | 0 | 0 | 090000648056b947 | |||
| FDA-1995-N-0054-13911 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:28:40Z | 0 | 0 | 090000648056b92f | |||
| FDA-1995-N-0054-13912 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:31:17Z | 0 | 0 | 090000648056b931 | |||
| FDA-1995-N-0054-13931 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:29:25Z | 0 | 0 | 090000648056b978 | |||
| FDA-1995-N-0054-13925 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:31:17Z | 0 | 0 | 090000648056b94d | |||
| FDA-1995-N-0054-13943 | FDA | Ephedrine Alkaloids: Reports of Adverse Events; Availability FDA-1995-N-0054 | Background Information to NPR1 | Supporting & Related Material | BKG-Background Material | 1997-06-06T04:00:00Z | 1997 | 6 | 2008-05-16T22:31:18Z | 0 | 0 | 090000648056b996 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;